Celator Pharma Surprises With Blood Cancer Drug Survival Benefit
Sentiment: Strong Buy
meant to put in the rest :
Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend
Second Sight to Announce Five-Year Data from Argus II Clinical Trial Program
Study Results Will Be Presented at 39th Annual Macula Society Meeting
Business Wire Second Sight Medical Products, Inc.
2 hours ago
SYLMAR, Calif.--(BUSINESS WIRE)--
Second Sight Medical Products, Inc. (EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced it will unveil five-year outcomes associated with the Argus® II Retinal Prosthesis System ("Argus II") during the 39th Annual Macula Society Meeting, being held February 24-27, 2016, at Eden Roc Miami Beach. James Handa, MD, the Robert Bond Welch Professor of Ophthalmology at the Johns Hopkins University Wilmer Eye Institute, will present the data for the first time during a session on Inherited Retinal Degeneration on Wednesday, February 24th at 6:12 p.m. Eastern Time.
Fitbit Reports $712M Q415 and $1.86B FY15 Revenue; Guides to $2.4 to $2.5B Revenue in FY16
Guides FY16 Non-GAAP Gross Margin of 48.5% to 49.0%
Business Wire Fitbit, Inc.
This Little Nugget Of An ETF Is Delivering Astounding Returns
Here's The DD for Newbies
Titan Pharma and Braeburn Pharmaceuticals receive FDA recommendation for Probuphine (TTNP) :
Titan Pharmaceuticals and partner Braeburn Pharmaceuticals announced that the PsychopharmacologicDrugs Advisory Committee of the FDA voted in favor of approving Probuphine, the first long-acting,subdermal buprenorphine implant for the maintenance treatment of opioid, painkiller addiction and relapse patients
CYBR the best of them ! Extreme Undervalued for winning Homeland Security Award.